$VGNT

Versigent's Strong FCF generation, Low Multiple Imply Further Upside, RBC Capital Markets Says

Versigent's (VGNT) robust free cash flow generation and a relatively low price-to-earnings multiple indicate there could be further upside as the company continues to demonstrate strength in its wire harness capabilities in a difficult automotive backdrop, RBC Capital Markets said in a note Tuesday.The company's raised 2026 net sales guidance is driven by higher commodity inflation, while a reaffirmed EBITDA guidance could indicate solid H2 margin expansion, supported by seasonality, copper recovery normalization, and operational performance, the investment firm said.Near-term focus remains on commercial vehicles and agriculture, where management sees meaningful scope for share gains, given it is now investing in go-to-market capabilities, according to the note.RBC Capital Markets upgraded the stock to outperform from sector perform, and boosted its price target to $52 per share from $41.Shares of Versigent were 0.2% lower in Wednesday trading.Price: $45.73, Change: $-0.07, Percent Change: -0.16%

RBC Capital Upgrades Versigent to Outperform From Sector Perform, Adjusts Price Target to $52 From $41

Versigent PLC (VGNT) has an average rating of buy and mean price target of $53.91, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Goldman Sachs Initiates Versigent at Buy With $48 Price Target

Versigent PLC (VGNT) has an average rating of buy and mean price target of $50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

UBS Adjusts Versigent Price Target to $55 From $58, Maintains Buy Rating

UBS Adjusts Versigent Price Target to $55 From $58, Maintains Buy Rating

Deutsche Bank Upgrades Versigent to Buy From Hold, Lifts Price Target to $50 From $38

Versigent (VGNT) has an average rating of Buy and mean price target of $49.80, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

UBS Adjusts Price Target on Versigent to $58 From $49, Maintains Buy Rating

Versigent PLC (VGNT) has an average rating of buy and mean price target of $48, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $49.37, Change: $-0.84, Percent Change: -1.68%

Morgan Stanley Initiates Versigent at Overweight With $51 Price Target

Versigent (VGNT) has an average rating of buy and mean price target of $46.60, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Aptiv's Growth Outside Auto Demand Supports Outlook, RBC Says

Aptiv (APTV) may benefit from rising orders from Chinese carmakers and customers outside the auto industry, while cost recoveries and stronger H2 margins could help it meet its full-year target, RBC Capital Markets said Tuesday in a report.Aptiv's Q1 adjusted EBITDA beat expectations, driven by strength in its former electrical distribution systems unit, now spun off as Versigent (VGNT), the report said. Weakness in the intelligent systems unit partly offset the beat, with pressure from Ford (F) production disruptions and slower-than-expected progress on a major European automaker's program, RBC said.Management maintained its full-year adjusted EBITDA guidance of $2.4 billion, though the Q2 outlook implies Aptiv will need better margins later in the year to reach that target, RBC said.Aptiv's expansion outside autos looks positive, supported by new business wins in naval, space and energy-storage markets, though early investment may weigh on margins until the business grows, the report said.RBC maintained its outperform rating on Aptiv stock and its $81 price target. The company should be able to manage higher commodity expenses given its strong track record of recovering most of those costs from automaker customers, the report said.Price: $56.81, Change: $+1.98, Percent Change: +3.61%

UBS Adjusts Price Target on Versigent to $49 From $43, Maintains Buy Rating

Versigent (VGNT) has an average rating of buy and mean price target of $43.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $40.12, Change: $+2.62, Percent Change: +6.99%

Versigent Q1 Net Income Falls, Sales Rise

Versigent (VGNT) reported Q1 net income Tuesday of $81 million, down from $96 million a year earlier.Net sales for the quarter ended March 31 were $2.21 billion, up from $2.02 billion a year earlier.Analysts surveyed by FactSet expected $2.09 billion.The company said it expects 2026 revenue of $9.10 billion to $9.40 billion. Analysts surveyed by FactSet expect $9.25 billion.Shares of the company traded more than 5% higher in recent premarket activity Wednesday.Price: $39.39, Change: $+1.89, Percent Change: +5.04%

BNP Paribas Initiates Coverage on Versigent PLC With Outperform Rating, $41 Price Target

Deutsche Bank Initiates Coverage on Versigent With Buy Rating, $35 Price Target